immunological enhancement breast cancer pubmed ncbi abstract breast cancer complex disease aetiology multifactorial period development span decades clinical highly variable evaluation role immune response development control breast cancer complex substantial information disease immune response host defence reaction serve facilitate cancer development evidence variety sources including clinical-pathological investigations women show correlation intensity lymphocytic infiltration tumour mass poor prognosis studies breast cancer patients demonstrate similar correlation delayed hypersensitivity reactivity vitro assays immune reactivity tumour cell membranes non-specific antigens poor prognosis analyses cancer incidence chronically immunosuppressed kidney transplant recipients develop unexpectedly low incidence breast cancer conclusions human studies corroborated observations mouse mammary tumour models demonstrate immune enhancement breast cell proliferation vitro breast cancer development vivo potential mechanisms effects include production inflammatory cell infiltrates direct indirect modulators breast cell growth e g cytokines peptide steroid hormones enzymes involved steroid metabolism antibodies growth factors receptors immune facilitatory mechanisms overcome immune-based therapies applied successfully breast cancer 
